We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Panel Revokes Symbicort Patent

Law360 (October 18, 2007, 12:00 AM EDT) -- An appellate panel on Thursday revoked AstraZeneca Plc's European combination patent for the asthma treatment Symbicort, well over two years after the European Patent Office upheld its validity.

The EPO's Technical...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.